GlaxoSmithKline Gets Momelotinib with US$1.9 B Sierra Oncology Buyout
By Sasha Yachu
Pharma Deals Review: Vol 2022 Issue 4 (Table of Contents)
Published: 21 Apr-2022
DOI: 10.3833/pdr.v2022.i4.2685 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
GlaxoSmithKline (GSK) has agreed to acquire Sierra Pharma for US$55 per share, representing a total transaction value of US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS